Mckernan Ruth 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Jan 11, 2021
Insider Transaction Report
Form 4
Mckernan Ruth
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-01-04+80,945→ 80,945 totalExercise: $16.41Exp: 2031-01-04→ Common Stock (80,945 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in thirty-six (36) equal monthly installments over three (3) years beginning on January 4, 2021.